Standard Biotools Inc (LAB) financials · rev $85.3M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Standard Biotools Inc (LAB) rev $85.3M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $85.3M | $174.4M |
| Cost of Revenue | $42.8M | $90.2M |
| Gross Profit | $42.5M | $84.3M |
| Operating Income | -$110.2M | -$175.2M |
| Net Income | -$74.9M | -$138.9M |
| EPS (Diluted) | -$0.20 | -$0.52 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $567.8M | $612.3M |
| Current Assets | $454.3M | $375.9M |
| Cash & Equivalents | $120.9M | $166.7M |
| Inventory | $20.0M | $40.7M |
| PP&E | $19.3M | $42.6M |
| Total Liabilities | $143.5M | $140.6M |
| Current Liabilities | $108.3M | $65.9M |
| Long-term Debt | N/A | $299.0K |
| Total Debt | N/A | $299.0K† |
| Shareholders' Equity | $424.3M | $471.7M |
| Retained Earnings | -$1.26B | -$1.19B |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$74.3M | -$143.5M |
| CapEx | $8.30M | $8.36M |
| Investing Cash Flow | $27.4M | $363.2M |
| Financing Cash Flow | $570.0K | -$102.6M |
| Net Change in Cash | -$45.5M | $116.3M |
| Free Cash Flow | -$82.6M | -$151.8M |
FAQ
What is LAB P/E and revenue?
Standard Biotools Inc (LAB) rev $85.3M.
What is LAB revenue?
Standard Biotools Inc last cached revenue is $85.3M (FY2025).
Is LAB profitable?
Standard Biotools Inc last cached net income is -$74.9M (FY2025).
What are LAB total assets?
Standard Biotools Inc last cached total assets are $567.8M (FY2025).
What is LAB free cash flow?
Standard Biotools Inc last cached free cash flow is -$82.6M (FY2025).
Not investment advice. Cached statements, not a live tape.